Polycystic Ovary Syndrome - treatment update
DOI:
https://doi.org/10.12775/QS.2025.43.61348Keywords
Endocrine disorder, Polycystic Ovary Syndrome, Hyperandrogenism, Treatment, Infertility, OvulaionAbstract
Introduction:
Polycystic Ovary Syndrome (PCOS) is one of the most common endocrine disorders. It gets its name from the characteristic appearance of the ovaries observed in ultrasound imaging. Statistically, PCOS affects about 4-12% of women of reproductive age. PCOS can have
a variety of symptoms and courses, and its causes have not been fully understood. Women with PCOS are at a higher risk of developing diabetes, hypertension, hyperlipidemia, and endometrial cancer compared to their healthy peers. The purpose of our work is to discuss the available methods used in the treatment of this syndrome.
Materials and methods:
The review was based on the analysis of materials collected in the "Pubmed" database, books and other scientific articles.
Keyworlds: Endocrine disorder; Polycystic Ovary Syndrome; Hyperandrogenism; Treatment; Infertility; Ovulation
Conclusions:
Polycystic Ovary Syndrome (PCOS) remains an important issue that affects women’s functioning and their hormonal balance. A review of the literature has shown that the use of medications and supplements in the form of herbs and plants has a positive impact on women's hormonal health, contributing to the regulation of the menstrual cycle and the stimulation of ovulation. Further research on the use of herbs is necessary, as based on the current sources, no definitive conclusions can be drawn.
References
1. Gynecology volume II 2021 Grzegorz H. Bręborowicz Chapter 12 Gynecological Endocrinology 12.7.2 Polycystic Ovary Syndrome 197-202 ISBN 978-83-200-6062-1
2. 4.Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H., Futterweit W., Janssen O.E., Legro R., Norman R., Taylor A.E., et al. Positions Statement: Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline. J. Clin. Endocrinol. Metab. 2006;91:4237–4245. doi: 10.1210/jc.2006-0178.[DOI] [PubMed] [Google Scholar]
3. Clomiphene Marilyn K. Mbi Feh 1, Preeti Patel, Roopma Wadhwa 2 PMID: 32644718 Bookshelf ID: NBK559292
4. Summary of Product Characteristics (SmPC) Clostilbegyt 50 mg.
5. The effect of laparoscopic ovarian drilling on pregnancy outcomes in polycystic ovary syndrome women with more than 2 in-vitro fertilization cycle failures: A pilot RCT PMID: 38292507 PMCID: PMC10823117 DOI: 10.18502/ijrm.v21i11.14653
6. Summary of Product Characteristics (SmPC) Metformax 500
7. Metformin: a review of its potential indications PMCID: PMC5574599 PMID: 28860713
8. Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS) PMID: 11524214 DOI: 10.1016/s1054-139x(01)00202-6
9. Spironolactone in the treatment of polycystic ovary syndrome PMID: 27450358 DOI: 10.1080/14656566.2016.1215430
10. Managing acne vulgaris: an update Miriam Santer 1, Esther Burden-Teh 2, Jane Ravenscroft 3 PMID: 38154809 PMCID: PMC10803966 DOI: 10.1136/dtb.2023.000051
11. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials PMCID: PMC9878965 PMID: 36703143
12. Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome https://doi.org/10.1080/09513590.2023.2301554
13. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines
14. Heshmati J, Moini A, Sepidarkish M, Morvaridzadeh M, Salehi M, Palmowski A, et al. Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Phytomedicine (2021) 80:153395. doi: 10.1016/j.phymed.2020.153395 [DOI] [PubMed] [Google Scholar]
15. Giordano A, Tommonaro G. Curcumin and cancer. Cur Cancer (2019) 11(10):2376. doi: 10.3390/nu11102376 [DOI] [PMC free article] [PubMed] [Google Scholar]
16. Reddy PS, Begum N, Mutha S, Bakshi V. Beneficial effect of Curcumin in Letrozole induced polycystic ovary syndrome. Asian Pac J Reprod (2016) 5(2):116–22. doi: 10.1016/j.apjr.2016.01.006 [DOI] [Google Scholar]
17. Kamal DAM, Salamt N, Yusuf ANM, Kashim MIAM, Mokhtar MH. Potential health benefits of curcumin on female reproductive disorders: A review. Nutrients (2021) 13(9):3126. doi: 10.3390/nu13093126 [DOI] [PMC free article] [PubMed] [Google Scholar]
18. Sharafieh G, Salmanifarzaneh F, Gharbi N, Sarvestani FM, Rahmanzad F, Razlighi MR, et al. Histological and molecular evaluation of Mentha arvensis extract on a polycystic ovary syndrome rat model. JBRA Assisted Reprod (2023) 27(2):247. [DOI] [PMC free article] [PubMed] [Google Scholar]
19. Çam M, Dinç Işıklı M, Yüksel E, Alaşalvar H, Başyiğit B. Application of pressurized water extraction and spray drying techniques to produce soluble spearmint tea. J Food Meas Charact (2018) 12(3):1927–34. [Google Scholar]
20. Amoura M, Lotfy ZH, Neveen E, Khloud A. Potential effects of Mentha piperita (peppermint) on Letrozole-induced polycystic ovarian syndrome in female albino rat. Int J (2015) 3(10):211–26. [Google Scholar]
21. Ataabadi MS, Alaee S, Bagheri MJ, Bahmanpoor S. Role of essential oil of Mentha spicata (Spearmint) in addressing reverse hormonal and folliculogenesis disturbances in a polycystic ovarian syndrome in a rat model. Advanced Pharm Bull (2017) 7(4):651. [DOI] [PMC free article] [PubMed] [Google Scholar]
22. Akdoğan M, Tamer MN, Cüre E, Cüre MC, Köroğlu BK, Delibaş N. Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism. Phytother Res (2007) 21(5):444–7. doi: 10.1002/ptr.2074 [DOI] [PubMed] [Google Scholar]
23. Chitra V, Dhivya DP. Role of herbal in management of polycystic ovarian syndrome and its associated symptoms. Int J Herbal Medicines (2017) 5(5):125–31. [Google Scholar]
24. Esmaeilinezhad Z, Babajafari S, Sohrabi Z, Eskandari M-H, Amooee S, Barati-Boldaji RJN, Metabolism et alet al. Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutrition, Metabolism and Cardiovascular Diseases (2019) 29(2):201–8. doi: 10.1016/j.numecd.2018.07.002 [DOI] [PubMed] [Google Scholar]
25. Ribeiro-Santos R, Andrade M, Madella D, Martinazzo AP, Moura LdAG, de Melo NR, et al. Revisiting an ancient spice with medicinal purposes: Cinnamon. Trends Food Sci Technol (2017) 62:154–69. doi: 10.1016/j.tifs.2017.02.011 [DOI] [Google Scholar]
26. Pachiappan S, Ramalingam K, Balasubramanian A. A review on phytomedicine and their mechanism of action on PCOS. Int J Curr Res Rev (2020) 12(23):81. doi: 10.31782/IJCRR.2020.122322 [DOI] [Google Scholar]
27. Guo X, Sun W, Huang L, Wu L, Hou Y, Qin L, et al. Effect of cinnamaldehyde on glucose metabolism and vessel function. Int Med J Exp Clin Res (2017) 23:3844. doi: 10.12659/MSM.906027 [DOI] [PMC free article] [PubMed] [Google Scholar]
28. Kort DH, Lobo RA. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. Am J Obstet Gynecol (2014) 211(5):487.e1–6. doi: 10.1016/j.ajog.2014.05.009 [DOI] [PubMed] [Google Scholar]
29. Zhang C, Fan L, Fan S, Wang J, Luo T, Tang Y, et al. Cinnamomum cassia Presl: a review of its traditional uses, phytochemistry, pharmacology and toxicology. Molecules (2019) 24(19):3473. doi: 10.3390/molecules24193473 [DOI] [PMC free article] [PubMed] [Google Scholar]
30. Arentz S, Smith CA, Abbott J, Bensoussan A. Herbal medicine for the management of polycystic ovary syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. Complementary Altern Medicines (2014) 14(1):119. doi: 10.1186/1472-6882-14-511 [DOI] [PMC free article] [PubMed] [Google Scholar]
31. Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome.Zhi Wang, Kexin Nie, Hao Su, Yueheng Tang, Hongzhan Wang, Xiaohu Xu, Hui Dong PMID: 34333328 DOI: 10.1016/j.phymed.2021.153654
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Marta Szymura, Marek Jarosław Molenda, Oliwia Brygida Woszczyńska, Paweł Maciej Rycąbel, Mateusz Romaniuk, Maria Wachowska, Mateusz Paniak, Agnieszka Ewelina Wojciechowska, Michał Brunon Krawczyk, Wojciech Jan Sowiński
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 296
Number of citations: 0
